Integra looks to boost margins with plant closures
This article was originally published in Clinica
Executive Summary
Integra LifeSciences is to close two manufacturing facilities as it continues to attempt to expand its margins, making it the latest medtech firm to turn to cost-cutting measures. The company will also drop several lower-margin/lower-growth product lines.